PAVmed Inc. (PAVM) Earnings History
Annual and quarterly earnings data from 2014 to 2024
Loading earnings history...
PAVM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PAVM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -101.6% | -1485.4% | 1328.6% |
| 2023 | -161.8% | -2805.7% | -2617.3% |
| 2022 | -858.6% | -24161.0% | -23602.9% |
| 2021 | -17.0% | -10878.6% | -10069.4% |
| 2020 | - | - | - |
Download Data
Export PAVM earnings history in CSV or JSON format
Free sign-in required to download data
PAVmed Inc. (PAVM) Earnings Overview
As of May 8, 2026, PAVmed Inc. (PAVM) reported trailing twelve-month net income of -$6.32B, reflecting +105.4% year-over-year growth. The company earned $-0.29 per diluted share over the past four quarters, with a net profit margin of 1328.6%.
Looking at the long-term picture, PAVM's historical earnings data spans multiple years. The company achieved its highest annual net income of $40M in fiscal 2024, representing a new all-time high.
PAVmed Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), INVA ($504M net income, 63.8% margin), MGRX (-$20M net income, -1413.6% margin), PAVM has outperformed on profitability metrics. Compare PAVM vs NVCR →
PAVM Earnings vs Peers
Earnings metrics vs comparable public companies
PAVM Historical Earnings Data (2014–2024)
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $40M | +162.0% | -$44M | $0.50 | 1328.6% | -1485.4% |
| 2023 | -$64M | +27.9% | -$69M | $-9.16 | -2617.3% | -2805.7% |
| 2022 | -$89M | -76.7% | -$91M | $-15.03 | -23602.9% | -24161.0% |
| 2021 | -$50M | -46.9% | -$54M | $-9.80 | -10069.4% | -10878.6% |
| 2020 | -$34M | -115.1% | -$23M | $-10.93 | - | - |
| 2019 | -$16M | +11.3% | -$14M | $-8.31 | - | - |
| 2018 | -$18M | -88.8% | -$11M | $-12.63 | - | - |
| 2017 | -$10M | -68.5% | -$8M | $-11.55 | - | - |
| 2016 | -$6M | -218.1% | -$6M | $-6.60 | - | - |
| 2015 | -$2M | -223.7% | -$2M | $-2.00 | - | - |
See PAVM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PAVM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PAVM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPAVM — Frequently Asked Questions
Quick answers to the most common questions about buying PAVM stock.
Is PAVM growing earnings?
PAVM EPS is $-0.29, with earnings growth accelerating to +105.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-6.3B.
What are PAVM's profit margins?
PAVmed Inc. net margin is +1328.6%, with operating margin at -1485.4%. Above-average margins indicate pricing power.
How consistent are PAVM's earnings?
PAVM earnings data spans 2014-2024. The accelerating earnings trend is +105.4% YoY. Historical data enables comparison across business cycles.